Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7075)
All Articles published online
|
May 28, 2009 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey. World J Gastroenterol 2009; 15(20): 2433-2440 [PMID: 19468990 DOI: 10.3748/wjg.15.2433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i20/2433.htm |
| Number | Citing Articles |
| 1 |
A. Cequera, M.C. García de León Méndez. Biomarkers for liver fibrosis: Advances, advantages and disadvantages. Revista de Gastroenterología de México (English Edition) 2014; 79(3): 187 doi: 10.1016/j.rgmxen.2014.07.001
|
| 2 |
Elif Ozdogan, Cigdem Arikan. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy. Clinical and Experimental Pediatrics 2023; 66(3): 110 doi: 10.3345/cep.2022.00367
|
| 3 |
Waleed Ghanima, Peter Junker, Hans Carl Hasselbalch, Leonardo Boiocchi, Julia T. Geyer, Xingmin Feng, Sif Gudbrandsdottir, Attilio Orazi, James B. Bussel. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents. British Journal of Haematology 2011; 155(2): 248 doi: 10.1111/j.1365-2141.2011.08845.x
|
| 4 |
Axel M. Gressner, Torsten Arndt. Lexikon der Medizinischen Laboratoriumsdiagnostik. 2013; : 477 doi: 10.1007/978-3-642-12921-6_6
|
| 5 |
Timo Rath, Lisa Hage, Marion Kügler, Katrin Menendez Menendez, Reinhart Zachoval, Lutz Naehrlich, Richard Schulz, Martin Roderfeld, Elke Roeb, Dominik Hartl. Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease. PLoS ONE 2013; 8(3): e58955 doi: 10.1371/journal.pone.0058955
|
| 6 |
Gavin E. Arteel, David W. Crabb. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 41 doi: 10.1007/978-3-319-20538-0_3
|
| 7 |
Tomislav Horvat, Brigitte Landesmann, Alfonso Lostia, Mathieu Vinken, Sharon Munn, Maurice Whelan. Adverse outcome pathway development from protein alkylation to liver fibrosis. Archives of Toxicology 2017; 91(4): 1523 doi: 10.1007/s00204-016-1814-8
|
| 8 |
Sakil Kulkarni, Stephen M. Roper, Janis M. Stoll. Biochemical and Molecular Basis of Pediatric Disease. 2021; : 229 doi: 10.1016/B978-0-12-817962-8.00030-5
|
| 9 |
Keyur Patel. Noninvasive tools to assess liver disease. Current Opinion in Gastroenterology 2010; 26(3): 227 doi: 10.1097/MOG.0b013e3283383c68
|
| 10 |
Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. . Advances in Clinical Chemistry 2013; 61: 67 doi: 10.1016/B978-0-12-407680-8.00004-X
|
| 11 |
A. M. Gressner, O. A. Gressner. Lexikon der Medizinischen Laboratoriumsdiagnostik. 2017; : 1 doi: 10.1007/978-3-662-49054-9_1162-1
|
| 12 |
Dieter Vanderschaeghe, Ákos Szekrényes, Christian Wenz, Marcus Gassmann, Natasha Naik, Maggie Bynum, Hongfeng Yin, Joris Delanghe, Andras Guttman, Nico Callewaert. High-Throughput Profiling of the Serum N-Glycome on Capillary Electrophoresis Microfluidics Systems: Toward Clinical Implementation of GlycoHepatoTest. Analytical Chemistry 2010; 82(17): 7408 doi: 10.1021/ac101560a
|
| 13 |
Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese. Molecular Serum Markers of Liver Fibrosis. Biomarker Insights 2012; 7: BMI.S10009 doi: 10.4137/BMI.S10009
|
| 14 |
Toru Mizuguchi, Masaki Kawamoto, Makoto Meguro, Thomas T. Hui, Koichi Hirata. Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surgery Today 2014; 44(1): 1 doi: 10.1007/s00595-013-0534-4
|
| 15 |
Timo Rath, Katrin Menendez Menendez, Marion Kügler, Lisa Hage, Christian Wenzel, Richard Schulz, Jürgen Graf, Lutz Nährlich, Elke Roeb, Martin Roderfeld. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease. Digestive and Liver Disease 2012; 44(9): 780 doi: 10.1016/j.dld.2012.04.008
|
| 16 |
Peter Jarčuška, Martin Janičko, Eduard Veselíny, Pavol Jarčuška, Ľubomír Skladaný. Circulating markers of liver fibrosis progression. Clinica Chimica Acta 2010; 411(15-16): 1009 doi: 10.1016/j.cca.2010.04.009
|
| 17 |
Toni Segovia-Silvestre, Vedrana Reichenbach, Guillermo Fernández-Varo, Efstathios Vassiliadis, Natasha Barascuk, Manuel Morales-Ruiz, Morten A Karsdal, Wladimiro Jiménez. Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis. Fibrogenesis & Tissue Repair 2011; 4(1) doi: 10.1186/1755-1536-4-19
|
| 18 |
A. Cequera, M.C. García de León Méndez. Biomarcadores para fibrosis hepática, avances, ventajas y desventajas. Revista de Gastroenterología de México 2014; 79(3): 187 doi: 10.1016/j.rgmx.2014.05.003
|
| 19 |
E. Roeb. Diagnostik der nichtalkoholischen Steatohepatitis. Der Gastroenterologe 2010; 5(2): 108 doi: 10.1007/s11377-009-0372-5
|
| 20 |
Roy A. Sherwood, Adrian Bomford. Clinical Biochemistry: Metabolic and Clinical Aspects. 2014; : 231 doi: 10.1016/B978-0-7020-5140-1.00013-4
|
| 21 |
Waleed Ghanima, Leonardo Boiocchi, Christina S. Lee, Xingmin Feng, Julia Turbiner Geyer, Sif Gudbrandsdottir, Attilio Orazi, Peter Junker, James B. Bussel. Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment. Platelets 2019; 30(2): 222 doi: 10.1080/09537104.2017.1411586
|
| 22 |
Mohamed M. Omran, Khaled Farid, Tarek M. Emran, Ahmed A. Attallah. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab Journal of Gastroenterology 2011; 12(2): 74 doi: 10.1016/j.ajg.2011.04.006
|
| 23 |
Minnie Malik, James Segars, William H. Catherino. Integrin β1 regulates leiomyoma cytoskeletal integrity and growth. Matrix Biology 2012; 31(7-8): 389 doi: 10.1016/j.matbio.2012.09.005
|
| 24 |
Tomomi Masuda, Eiji Miyoshi. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics. cclm 2011; 49(6): 959 doi: 10.1515/CCLM.2011.152
|
| 25 |
Valeria R Mas, Robert A Fisher, Kellie J Archer, Daniel G Maluf. Proteomics and liver fibrosis: identifying markers of fibrogenesis. Expert Review of Proteomics 2009; 6(4): 421 doi: 10.1586/epr.09.59
|
| 26 |
A. M. Gressner, O. A. Gressner. Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin 2019; : 899 doi: 10.1007/978-3-662-48986-4_1162
|
| 27 |
Diana Vetter, Scott L. Friedman. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 110 doi: 10.1016/B978-0-323-34062-5.00007-8
|
| 28 |
Abdurrahman Sagir, Birgit Glaubach, Kurtulus Sahin, Dirk Graf, Andreas Erhardt, Mark Oette, Dieter Häussinger. Transient Elastography for the Detection of Liver Damage in Patients with HIV. Infectious Diseases and Therapy 2015; 4(3): 355 doi: 10.1007/s40121-015-0073-y
|
| 29 |
Dieter Vanderschaeghe, Andras Guttman, Nico Callewaert. Clinical Applications of Capillary Electrophoresis. Methods in Molecular Biology 2013; 919: 87 doi: 10.1007/978-1-62703-029-8_9
|
| 30 |
MM Sira, HA El-Araby, EM Ghoneim, HA Konsowa, EH El-Mwafy. Serum YKL-40 (Chitinase-3-Like Protein 1) Compared to APRI and FIB-4 in Predicting Liver Fibrosis in Children with Chronic Hepatitis C. Archives of Hepatitis Research 2016; 2(1): 015 doi: 10.17352/ahr.000006
|
| 31 |
Matthew L. Cowan, Tony M. Rahman, Sanjeev Krishna. Proteomic approaches in the search for biomarkers of liver fibrosis. Trends in Molecular Medicine 2010; 16(4): 171 doi: 10.1016/j.molmed.2010.01.006
|
| 32 |
Timo Rath, Martin Roderfeld, Can Güler, Christian Wenzel, Jürgen Graf, Frigga Beitinger, Elke Roeb, Reinhart Zachoval. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scandinavian Journal of Gastroenterology 2011; 46(11): 1369 doi: 10.3109/00365521.2011.613949
|
| 33 |
J.I. Beier, G.E. Arteel. Comprehensive Toxicology. 2018; : 443 doi: 10.1016/B978-0-12-801238-3.95666-6
|
| 34 |
Olav A. Gressner, Meng Fang, Hui Li, Lun Gen Lu, Axel M. Gressner, Chun Fang Gao. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection. Clinica Chimica Acta 2013; 421: 126 doi: 10.1016/j.cca.2013.02.029
|
| 35 |
Medi Kori, Busra Aydin, Gizem Gulfidan, Hande Beklen, Nurdan Kelesoglu, Ayşegul Caliskan Iscan, Beste Turanli, Can Erzik, Betul Karademir, Kazim Yalcin Arga. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers. OMICS: A Journal of Integrative Biology 2021; 25(3): 139 doi: 10.1089/omi.2020.0210
|
| 36 |
Nora El-Bassiouni, Noha Amin, S. H. Rizk, M. K. Abo El Azayem, Mona Madkour, Hasan Garem, Raafat Ibrahim, Ola Abo El Nil. Role of Circulating Hematopoietic Fibrocytes in Chronic Hepatitis C Patients Induced Liver Fibrosis. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1222 doi: 10.3889/oamjms.2022.8123
|
| 37 |
Jung Yeon Joo, In Hyuk Yoo, Hye Ran Yang. Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis. Pediatric Gastroenterology, Hepatology & Nutrition 2024; 27(4): 236 doi: 10.5223/pghn.2024.27.4.236
|
| 38 |
Daniela Cesselli, Antonio Paolo Beltrami, Alessandra Poz, Stefania Marzinotto, Elisa Comisso, Natascha Bergamin, Evgenia Bourkoula, Anja Pucer, Elisa Puppato, Barbara Toffoletto, Marisa Sorrentino, Umberto Baccarani, Claudio Avellini, Carlo Alberto Beltrami. Role of Tumor Associated Fibroblasts in Human Liver Regeneration, Cirrhosis, and Cancer. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/120925
|
| 39 |
Konstantinos Kalogeropoulos, Louise Bundgaard, Ulrich auf dem Keller. Extracellular Matrix Omics. Biology of Extracellular Matrix 2020; 7: 157 doi: 10.1007/978-3-030-58330-9_8
|
| 40 |
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, Lakshmaiah Venkataswamy, Muninarayana Chandrappa. Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease Progression. Future Science OA 2018; 4(1) doi: 10.4155/fsoa-2017-0083
|
| 41 |
Ulises Osuna-Martínez, Jorge Alberto Reyes-Esparza, Vera L. Petricevich, Rogelio Hernández-Pando, Lourdes Rodríguez-Fragoso. Protective effect of Thymic Humoral Factor on porcine serum-induced hepatic fibrosis and liver damage in Wistar rats. Annals of Hepatology 2011; 10(4): 540 doi: 10.1016/S1665-2681(19)31523-6
|
| 42 |
Jin-Wook Kim, Sang Hyub Lee, Sook-Hyang Jeong, Haeryoung Kim, Keun Soo Ahn, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han. Increased Urinary Lipocalin-2 Reflects Matrix Metalloproteinase-9 Activity in Chronic Hepatitis C with Hepatic Fibrosis. The Tohoku Journal of Experimental Medicine 2010; 222(4): 319 doi: 10.1620/tjem.222.319
|
| 43 |
R. Mihaylov, B. Pencheva, D. Stoeva, A. Ruseva. Non-invasive Diagnostics of Liver Fibrosis. Acta Medica Bulgarica 2017; 44(1): 50 doi: 10.1515/amb-2017-0009
|
| 44 |
José M. Ladero, María C. Cárdenas, Luis Ortega, Andrea González-Pino, Francisca Cuenca, César Morales, Anna Lee-Brunner. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?. Annals of Hepatology 2012; 11(5): 648 doi: 10.1016/S1665-2681(19)31437-1
|
| 45 |
Lakshmi Pasumarthy, James Srour. Nonalcoholic Steatohepatitis: A Review of the Literature and Updates in Management. Southern Medical Journal 2010; 103(6): 547 doi: 10.1097/SMJ.0b013e3181de0ce0
|